Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion

NCT00190788 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis
Hypotension

Interventions

DRUG: Drotrecogin Alfa (Activated)
DRUG: placebo

Sponsor

Eli Lilly and Company